Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Bravo G Montalban, MD
CONTACT
Lead
M.D. Anderson Cancer Center
With
Primary Objectives * To determine the safety and tolerability of imetelstat in MDS/MPN * To assess efficacy (overall response (OR) rate) of imetelstat in MDS/MPN based on 2015 MDS/MPN IWG response criteria. * Incidence of AEs, maximum tolerated dose (MTD) and changes in clinical laboratory values. * Measures of efficacy: overall response rate (ORR) defined as sum of CR + complete cytogenetic remission + partial remission + marrow response + clinical benefit according to the IWG 2015 MDS/MPN response criteria.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
